Skip to main content
Top

Determinants of left ventricular mass in children with autosomal recessive polycystic kidney disease

Published in:

Abstract

Background

Hypertension and left ventricular (LV) hypertrophy (LVH) are common in autosomal recessive polycystic kidney disease (ARPKD). We examined clinical determinants of LV mass in children with ARPKD.

Methods

Retrospective study of patients with ARPKD with available echocardiogram data. Casual blood pressure (BP) percentiles, 24-h ambulatory BP monitor (ABPM) parameters, antihypertensive medications, and estimated glomerular filtration rate (eGFR) within 6 months of echocardiogram were collected. Outcomes included LV mass Z-score, LV mass index [LVMI in g/m2.7 and g/(m2.16 + 0.09)], and LVH.

Results

Thirty patients with ARPKD (median age 7.2 years [IQR 3.4, 12.8]) had echocardiograms, 28 had casual BPs, 11 had ABPMs, and 93% were on antihypertensives. LVH occurred in 23% based on LVMI in g/m2.7 > 95th percentile, and in 50% based on LVMI > 45 g/(m2.16 + 0.09). Younger age correlated with higher number of antihypertensives (ρ = − 0.46, P = 0.014) and higher casual systolic and diastolic BP percentiles (r = − 0.74, P < 0.001; r = − 0.81, P < 0.001). After adjusting for age, sex, and eGFR, LV mass was not significantly associated with casual BP or ABPM, except for a negative association between LV mass Z-score and casual diastolic BP percentile (β coefficient − 0.31, P = 0.04). After adjusting for age, sex, and casual BP, both LVMI [in g/m2.7 and g/(m2.16 + 0.09)] and LV mass Z-score were significantly negatively associated with eGFR (β –1.08, P = 0.003; β –0.79, P = 0.007; and β -0.07, P = 0.01, respectively).

Conclusions

Young children with ARPKD have a higher burden of hypertension. LV mass was unexpectedly not significantly associated with BP but was negatively associated with eGFR.

Graphical abstract

Title
Determinants of left ventricular mass in children with autosomal recessive polycystic kidney disease
Authors
Mathew Lin
Jeremy Rubin
Robert A. Palermo
Jarcy Zee
Erum A. Hartung
Publication date
07-10-2025
Publisher
Springer International Publishing
Published in
Journal of Nephrology / Issue 9/2025
Print ISSN: 1121-8428
Electronic ISSN: 1724-6059
DOI
https://doi.org/10.1007/s40620-025-02426-y
This content is only visible if you are logged in and have the appropriate permissions.
This content is only visible if you are logged in and have the appropriate permissions.
SPONSORED

Adherence to injectables

In this podcast, Professor Jorge Sánchez shares his insights into identifying and addressing poor adherence to injectable therapy, offering guidance that can help to support patients with chronic diseases through their treatment journey.

Sponsor:
  • Novartis Pharma AG
Prof. Jorge Sánchez
Listen now
Podcast

Keynote webinar | Spotlight on dry eye disease

  • Live
  • Webinar | 28-05-2026 | 13:00 (CEST)

DED is highly prevalent yet challenging to diagnose and treat. Join leading experts to explore the latest developments and gain practical guidance on effective management in busy clinical settings. Brought to you by Springer Medicine and Eye.

Watch it live: 28 May 2026, 13:00–14:00 (CEST)

Prof. Harminder Dua
Prof. Sajjad Ahmad
Prof. Anat Galor
Join the webinar
Webinar
Image Credits
Adis Journal Podcast/© Adis, Conceptual illustration of dry eye disease/© Science Photo Library / Getty Images